Depomed Up 6.7% After Hitting 52-Week High (DEPO)

Shares of Depomed, Inc. DEPO are trading up 6.7% at $6.40 per share during the Tuesday afternoon trading session. The day's trading range for shares of Depomed, Inc has been between $6.16 and a 52-week high of $6.43 per share. Analysts covering Depomed, Inc. (DEPO) stock give it a consensus price target of $7.50 per share. Trading volume for Depomed, Inc has been heavy, with 1.3 million shares having been traded today, already more than triple the daily average volume of 494,000 shares. Depomed, Inc is a specialty pharmaceutical company with one product candidate through Phase 3 clinical development, another in Phase 3 clinical development, two approved products on the market and other product candidates in its early stage pipeline. Read more from Benzinga's Company news.